Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Rational Extra-eloquent Closed-loop Cortical Stimulation (REC2Stim) as a Treatment for Refractory Epilepsy in the Primary Sensorimotor Cortex.

NCT04158531 is registered in ClinicalTrials.gov with UMC Utrecht as lead sponsor.

NCT NCT04158531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04158531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Rational Extra-eloquent Closed-loop Cortical Stimulation (REC2Stim) as a Treatment for Refractory Epilepsy in the Primary Sensorimotor Cortex.
Lead sponsor
UMC Utrecht
Phase
Not applicable
Overall status
Unknown status
Start date
November 4, 2019
Completion date
July 31, 2022
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy intractable, epileptic seizure, motor seizure